Fake News on Twitter During the 2016 U.S. Presidential Election
The spread of fake news on social media became a public concern in the United States after the 2016 presidential election. This article examines exposure to and sharing of fake news by registered voters on Twitter.
Despite some notable progress in data sharing policies and practices, restrictions are still often placed on the open and unconditional use of various genomic data after they have received official approval for release to the public domain or to public databases.
How to Shine in Indonesian Science? Game the System
Indonesia researchers have inflated their Indonesia’s Science and Technology Index (SINTA) score by publishing large numbers of papers in low-quality journals, citing their own work excessively, or forming networks of scientists who cited each other.
Climate Change Poses Major Threat to U.S., New Government Report Concludes
Climate already affecting communities, and effects will get worse without action. The new report is designed to be “policy relevant,” but does not make specific policy recommendations, federal officials associated with the U.S. Global Change Research Program noted.
Relationship of Gender Differences in Preferences to Economic Development
What contributes to gender-associated differences in preferences such as the willingness to take risks, patience, altruism, positive and negative reciprocity, and trust? Falk and Hermle studied 80,000 individuals in 76 countries who participated in a Global Preference Survey and compared the data with country-level variables. They observed that the more that women have equal opportunities, the more they differ from men in their preferences.
Elena Álvarez-Buylla will become the director of the National Council of Science and Technology in Mexico. While many scientists are delighted that she'll be the first woman to do so, critics worry about her opposition to genetically modified maize, which could spoil the country's astonishing agricultural biodiversity.
An investigative report uncovers little recognized and unpoliced potential conflicts of interest among those who serve on FDA advisory panels that review drugs. FDA may also have missed or judged insignificant financial ties physicians had before their service on the drug approval advisory panels.
Three steps that could be taken by funding agencies to support young investigators in more constructive and effective ways: (1) greatly expand the use of the New Innovator/Starting Grants awards, (2) increase the funding of young investigators through requests for applications, and (3) experiment with separate competitions for Early Stage Investigators when awarding traditional investigator-initiated R01 grants.